ANG Lifesciences India Ltd

Company Profile

ANG Lifesciences India Ltd had its IPO on under the ticker symbol ANG.

The company operates in the sector and industry. ANG Lifesciences India Ltd has a staff strength of 0 employees.

Stock update

Shares of ANG Lifesciences India Ltd opened at ₹75.79 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹69.4 - ₹75.79, and closed at ₹71.16.

This is a -4.21% slip from the previous day's closing price.

A total volume of 24,632 shares were traded at the close of the day’s session.

In the last one week, shares of ANG Lifesciences India Ltd have slipped by -5.66%.

ANG Lifesciences India Ltd's Key Ratios

ANG Lifesciences India Ltd has a market cap of ₹363.71 million, indicating a price to book ratio of 1.8375 and a price to sales ratio of 0.5988.

In the last 12-months ANG Lifesciences India Ltd’s revenue was ₹0 with a gross profit of ₹378.62 million and an EBITDA of ₹0. The EBITDA ratio measures ANG Lifesciences India Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, ANG Lifesciences India Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, ANG Lifesciences India Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

ANG Lifesciences India Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

5.9668

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ANG Lifesciences India Ltd’s profitability.

ANG Lifesciences India Ltd stock is trading at a EV to sales ratio of 0.7905 and a EV to EBITDA ratio of 5.4949. Its price to sales ratio in the trailing 12-months stood at 0.5988.

ANG Lifesciences India Ltd stock pays annual dividends of ₹ per share, indicating a yield of 0.32% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹2.80 billion

Total Liabilities

₹1.62 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

ANG Lifesciences India Ltd ended 2024 with ₹2.80 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹2.80 billion while shareholder equity stood at ₹862.18 million.

ANG Lifesciences India Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹1.62 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹3.24 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹205.35 million.

ANG Lifesciences India Ltd’s total current assets stands at ₹1.87 billion while long-term investments were ₹0 and short-term investments were ₹197.45 million. Its net receivables were ₹831.43 million compared to accounts payable of ₹681.86 million and inventory worth ₹484.87 million.

In 2024, ANG Lifesciences India Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, ANG Lifesciences India Ltd paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹71.16

52-Week High

₹203

52-Week Low

₹52.1

Analyst Target Price

₹

ANG Lifesciences India Ltd stock is currently trading at ₹71.16 per share. It touched a 52-week high of ₹203 and a 52-week low of ₹203. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹69.34 and 200-day moving average was ₹87.26 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.